# Single-arm, Multi-center Study Evaluating the Acceptance and Feasibility of a Digital Remote Monitoring Tool Configured for Patients With ATTR-CM: ACO-Monitor

> clinical trial · VERIFIED · 2026-06-11

Status: NOT_YET_RECRUITING · Sponsor: Bayer · Condition: Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

- Company: Bayer
- Sector: digital health
- Primary source: https://clinicaltrials.gov/study/NCT07557147

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.